ETH Zurich

ETH Zurich researchers have found a virus that kills dormant bacteria. This rare discovery could help to combat germs that can’t be treated with antibiotics alone.

Guillain-Barré Syndrome is a rare condition in which a person’s immune system attacks the peripheral nerves. People affected suffer from muscle weakness and paralysis. A research team led by ETH Zurich has now clarified the mechanism of this autoimmune disease.

A new model designed by ETH Zurich researchers measures how flexible medication distribution systems are in real time. It shows that supply shortages can be eased if pharmaceutical wholesalers coordinate their inventories and reroute scarce products as flexibly as possible along existing supply chains.

The Federal Department of Foreign Affairs (FDFA) and ETH Zurich, in collaboration with their international partners, are launching the International Computation and AI Network (ICAIN) at the World Economic Forum (WEF) 2024 in Davos. Its mission is to develop AI technologies that benefit society as a whole, as well as being accessible to all and sustainable, thereby helping to reduce global inequality.

In 2019, the tailings dam at a Brazilian iron ore mine failed. The mudslide caused a catastrophe for people and the environment. A team of researchers at ETH Zurich has now uncovered the physical mechanism that may have triggered the accident.